Open Access
Outcomes of Enfortumab Vedotin Treatment in Patients Ineligible for the EV-301 Trial
KAZUTAKA NAKAMURA, YUKI KOBARI, YUDAI ISHIYAMA, HANAE KONDO, TORU INAKAWA, YUKI NEMOTO, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, JUNPEI IIZUKA, HIROAKI SHIMMURA, HIROSHI KOBAYASHI, YASUNOBU HASHIMOTO, HIDEKI ISHIDA, TSUNENORI KONDO and TOSHIO TAKAGI
In Vivo September 2025, 39 (5) 2766-2776; DOI: https://doi.org/10.21873/invivo.14075